Heparin in patients with heparin-induced thrombocytopenia type II requiring LVAD implantation and cardiac transplantation

J Heart Lung Transplant. 2000 May;19(5):510-2. doi: 10.1016/s1053-2498(00)00089-9.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Anticoagulants* / administration & dosage
  • Anticoagulants* / adverse effects
  • Cardiomyopathy, Dilated / therapy
  • Cardiopulmonary Bypass
  • Decision Making
  • Female
  • Heart Diseases / chemically induced
  • Heart Transplantation*
  • Heart Ventricles
  • Heart-Assist Devices*
  • Heparin* / administration & dosage
  • Heparin* / adverse effects
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Myocardial Ischemia / therapy
  • Thrombocytopenia / chemically induced*
  • Thrombosis / chemically induced

Substances

  • Anticoagulants
  • Heparin